Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies.
Niedrist T, Kriegl L, Zurl CJ, Schmidt F, Perkmann-Nagele N, Mucher P, Repl M, Flieder I, Radakovics A, Sieghart D, Radner H, Aletaha D, Binder CJ, Gülly C, Krause R, Herrmann M, Wagner OF, Perkmann T, Haslacher H. Niedrist T, et al. Among authors: perkmann nagele n, perkmann t. Clin Chem Lab Med. 2022 Nov 4;61(2):332-338. doi: 10.1515/cclm-2022-0875. Print 2023 Jan 27. Clin Chem Lab Med. 2022. PMID: 36323338 Free article.
A risk prediction model for screening bacteremic patients: a cross sectional study.
Ratzinger F, Dedeyan M, Rammerstorfer M, Perkmann T, Burgmann H, Makristathis A, Dorffner G, Lötsch F, Blacky A, Ramharter M. Ratzinger F, et al. Among authors: perkmann t. PLoS One. 2014 Sep 3;9(9):e106765. doi: 10.1371/journal.pone.0106765. eCollection 2014. PLoS One. 2014. PMID: 25184209 Free PMC article. Clinical Trial.
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T, Berghoff AS, Heller G, Haslacher H, Perkmann T, Strassl R, Berger JM, Puhr HC, Kreminger J, Moik F, Schubert L, Starzer AM, Steindl A, Winkler S, Preusser M, Tobudic S. Fuereder T, et al. Among authors: perkmann t. ESMO Open. 2020 Sep;5(5):e000889. doi: 10.1136/esmoopen-2020-000889. ESMO Open. 2020. PMID: 32878898 Free PMC article.
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
Mrak D, Tobudic S, Koblischke M, Graninger M, Radner H, Sieghart D, Hofer P, Perkmann T, Haslacher H, Thalhammer R, Winkler S, Blüml S, Stiasny K, Aberle JH, Smolen JS, Heinz LX, Aletaha D, Bonelli M. Mrak D, et al. Among authors: perkmann t. Ann Rheum Dis. 2021 Oct;80(10):1345-1350. doi: 10.1136/annrheumdis-2021-220781. Epub 2021 Jul 20. Ann Rheum Dis. 2021. PMID: 34285048
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.
Simader E, Tobudic S, Mandl P, Haslacher H, Perkmann T, Nothnagl T, Sautner J, Radner H, Winkler F, Burgmann H, Mrak D, Aletaha D, Winkler S, Blüml S. Simader E, et al. Among authors: perkmann t. Ann Rheum Dis. 2022 Mar;81(3):416-421. doi: 10.1136/annrheumdis-2021-221347. Epub 2021 Nov 29. Ann Rheum Dis. 2022. PMID: 34844927
138 results